Experimental drug shows promise in reducing risk of Alzheimer’s-related dementia Een experimenteel medicijn lijkt het risico op Alzheimers-gerelateerde dementie te verminderen bij mensen die voorbestemd zijn om de ziekte te…
GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation New research shows how GLP-1 receptor drugs, known for treating diabetes and obesity, also protect the brain’s vital neurovascular system,…
Dronabinol shows promise in reducing agitation in Alzheimer’s patients In a study led by Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that…
Exploring the role of suvorexant in reducing delirium among older adults Delirium is a sudden and temporary state of disturbed consciousness or cognition that occurs due to underlying medical problems such…
